DTIL Precision BioSciences Long-Term Liabilities

Public company logo of precisionbiosciences.com (DTIL)

This chart of Precision BioSciences (DTIL) stock quotes reflects the performance of a company with a metric of 0.02. The business relies on its proprietary ARCUS system, which creates a protective barrier against patent conflicts. Ownership of this tool guarantees stable royalties from global pharma behemoths. The implementation of automated precision analysis stations is currently significantly reducing the timelines for preliminary research on new drugs.

DTIL Precision BioSciences, Inc.: Company Long-Term Debts in the range 07/04/2022 - 10/28/2026

Analytical breakdowns for Precision BioSciences, Inc. (DTIL)

- price and consensus price forecast:
Stock Price precisionbiosciences.com|DTIL - Price Target Chart
- market capitalization data:
Market Valuation Precision BioSciences|DTIL - Total Company Value
- book capitalization data:
Accounting Value of a Share Precision BioSciences|DTIL - Book Capitalization|Market-to-Book Ratio precisionbiosciences.com|DTIL - Company Total Assets
- debt and liquidity data:
Total Debt to Equity Ratio Precision BioSciences|DTIL - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient Precision BioSciences Inc.|DTIL - Company Debts|Debts to Net Assets Precision BioSciences|DTIL - Company Long-Term Debts|Short-Term Debt Volume Precision BioSciences
General company analysis:DTIL (precisionbiosciences.com)
Original product of Precision BioSciences, Inc.

Long-term debt aggregates all obligations with maturities exceeding twelve months, allowing for an assessment of capital structure stability and default risk in the absence of liquidity. When analyzing the current level of the firm's long-term borrowings, it is essential to consider the negative cash flow of Precision BioSciences (DTIL) resulting from ARCUS development costs, which makes credit load control a critical survival factor for the company.

Competing companies

Tempus Labs - Company Long-Term Debts|Company Long-Term Debt Qiagen|IONS: Long-Term Liabilities|Company Long-Term Debt Repligen Corp. RGEN|Avidity Corp (RNA) - Company Long-Term Loans and Borrowings|Company Long-Term Debts CRSP (CRISPR Therapeutics AG)|Long-Term Debt genedx.com|Company Long-Term Debts RARE (Ultragenyx)|Company Long-Term Liabilities Beam Therapeutics Inc (BEAM)|Company Long-Term Debts SRPT|Twist Bioscience Corp - Long-Term Debt Volume|Company Long-Term Debt TXG (10x Genomics, Inc.)|NTLA - Long-Term Debt Volume|Stoke Therapeutics, Inc. - Company Long-Term Debts|BLFS (BioLife Solutions Inc) - Long-Term Debt Volume|Company Long-Term Debt WVE (Wave Life Sciences Corp)|Long-Term Debt MAZE|Company Long-Term Debt Sionna Therapeutics Inc SION|Company Long-Term Indebtedness primemedicine.com PRME|Company Long-Term Liabilities Taysha Gene Therapies, Inc.|Company Long-Term Loans and Borrowings uniQure NV QURE|MGTX - Company Long-Term Debts|RGNX - Company Long-Term Debt|Solid Biosciences Inc. - Company Long-Term Debts|OCGN (ocugen.com) - Long-Term Debt Volume|Company Long-Term Debt PACB (PacBio)|Long-Term Debt BNTC|DSGN (Design Pharma) - Company Long-Term Debt|Long-Term Debt Volume Rocket Corp (RCKT)|4D Molecular Therapeutics - Company Long-Term Debts|Company Long-Term Liabilities Lexeo Therapeutics Inc. LXEO|Company Long-Term Debts KRRO (Korro Bio, Inc)|EDIT - Long-Term Debt Volume|Company Long-Term Debts SLN|PRQR (ProQR Therapeutics) - Long-Term Debt|Company Long-Term Debt Codexis Inc (CDXS)|Company Long-Term Indebtedness sangamo.com|Company Long-Term Debts NAUT (Nautilus Biotechnology)|Company Long-Term Liabilities Metagenomi Inc. (MGX)|GBIO: Company Long-Term Debts|Boundless Bio Inc - Long-Term Debt|Company Long-Term Debt XCUR (Exicure Corp)|IMNN - Long-Term Debt Volume|Company Long-Term Debts phiopharma.com|Company Long-Term Indebtedness Mustang Bio|TransCode Therapeutics Inc. (RNAZ) - Company Long-Term Liabilities|Amount of Long-Term Liabilities Bionano|APDN (Applied DNA Sciences) - Company Long-Term Debts|Long-Term Debt Volume BLUE (bluebirdbio.com)|Company Long-Term Debt ImmunoPrecise Antibodies Ltd. IPA|Company Long-Term Debt Omega Therapeutics Inc OMGA|Singular Genomics Systems Inc (OMIC) - Company Long-Term Debts|RGLS: Company Long-Term Indebtedness|Company Long-Term Debt Syros Pharmaceuticals|telesisbio.com (TBIO) - Company Long-Term Indebtedness|TCON (TRACON Pharmaceuticals, Inc.) - Company Long-Term Debts|Company Long-Term Debts UBX